SevenBridge Financial Group LLC Buys 2,511 Shares of Intuitive Surgical, Inc. $ISRG

SevenBridge Financial Group LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 46.2% during the third quarter, Holdings Channel.com reports. The firm owned 7,944 shares of the medical equipment provider’s stock after buying an additional 2,511 shares during the period. SevenBridge Financial Group LLC’s holdings in Intuitive Surgical were worth $3,553,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. State Street Corp raised its holdings in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares during the last quarter. Capital World Investors boosted its position in Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after buying an additional 116,034 shares during the period. Finally, Norges Bank bought a new stake in Intuitive Surgical in the 2nd quarter worth $2,569,260,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. The trade was a 50.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 37,907 shares of company stock worth $19,997,187. Insiders own 0.70% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG from Neutral to Buy with a $590 price target, signaling renewed Wall Street conviction and likely driving buying interest. Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott
• Positive Sentiment: Analyst and sector commentary highlight long-term growth from da Vinci 5 adoption and the broader robotic surgery market, supporting upside expectations. Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
• Positive Sentiment: Analysts point to da Vinci 5 momentum and continued procedure volume expansion (plus Ion and SP platform contributions) as drivers for recurring revenue growth into 2026. Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
• Positive Sentiment: ISRG completed the acquisition of several regional da Vinci and Ion distribution businesses, simplifying channels and potentially improving margins/recurring revenue capture. Intuitive Surgical Announces Completion of Acquisition of da Vinci and Ion Distribution Business
• Neutral Sentiment: Market commentary notes ISRG outperformed peers on a strong trading day, but without a single clear catalyst — short-term moves appear market- and sentiment-driven. Intuitive Surgical Inc. stock outperforms competitors on strong trading day
• Neutral Sentiment: Valuation analyses (and some sell‑side notes) show mixed returns: strong fundamentals and long-term returns versus recent momentum loss; this leaves the stock in a “growth at a premium” category. Assessing Intuitive Surgical (ISRG) Valuation As Shares Tread Water Despite Growth
• Negative Sentiment: Insider sales: several recent senior-exec stock sales (SVP Mark Brosius and EVP Myriam Curet among others) add selling pressure and raise short-term sentiment concerns. SEC Filing — Insider Sales
• Negative Sentiment: Management warned of a notable deceleration in worldwide da Vinci procedure growth for 2026, which could temper revenue/procedure growth expectations in the near term. Intuitive Surgical Stock: Buy, Sell, or Hold?
• Negative Sentiment: Valuation remains rich (P/E ~63 vs. historical average ~53.5), supporting cautious/hold views from some analysts despite strong margins and cash on the balance sheet. Intuitive Surgical – Strong Moat But Valuation Remains Elevated, Hold

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ISRG shares. HSBC boosted their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Finally, Truist Financial increased their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Stock Up 1.4%

ISRG opened at $492.87 on Thursday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88. The stock has a market cap of $175.03 billion, a PE ratio of 62.47, a PEG ratio of 3.75 and a beta of 1.66. The business has a 50 day moving average of $516.79 and a 200-day moving average of $512.60.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.